Parakeet Health raises a $10M Series A led by Canvas Ventures to expand AI patient outreach beyond dermatology.
Sanofi pays Regeneron $1B upfront, with up to $7B more, to co-develop four long-acting immunology antibodies as Dupixent's patent cliff nears.
The Centers for Medicare and Medicaid Services finalized a demonstration program aimed at lowering the prices of ...
Bristol Myers discloses a fatal liver injury in its Phase 3 program for pulmonary fibrosis drug admilparant ahead of a Q4 ...
Forget Wegovy and Zepbound. Never mind CagriSema, and even retatrutide. The latest big name in obesity is eloraTZP. Data ...
A California biotech launched on Tuesday morning to try to bring a niche pain drug, approved in Italy for more than a decade, to the US. Investors are pumping $125 million into the company ...
Merck's tulisokibart showed mid-stage success in hidradenitis suppurativa, with 72% high-dose patients seeing 50%+ abscess ...
Former House majority leader Eric Cantor has been chosen as PhRMA’s next CEO, according to two sources familiar ...
The cash should give the Stockholm-based biotech a runway “well into 2029,” CEO Patrik Strömberg told Endpoints News in ...
The American Biotech Innovation Alliance pressed Congress this week on US-China biotech competition, citing FDA capacity ...
ARCH and Population Health launch Somnivera with a $10.5M-upfront deal for an ex-China sleep drug from Jiangsu Nhwa.
Ex-Genentech AI leaders including NYU's Kyunghyun Cho launch health startup Ortet with a $500M commitment from Matt Holt's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results